The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows, the second cohort of emerging research leaders to receive the accolade. The selection process was a coordinated effort by the Oxford BRC and its partners in the NIHR Oxford Health BRC, which focuses on ... READ MORE
News for Gene and Cell Therapy
Oxford haematologists win national awards to further their research
Two consultant haematologists at the Oxford Haemophilia and Thrombosis Centre (OHTC), based at the Churchill Hospital, have been awarded funding for their research as part of a new national scheme. Dr Nicola Curry and Dr Susie Shapiro were among the recipients of the new Clinical Academic ... READ MORE
Study discovers genetic changes linked to leukaemia in children with Down’s syndrome
Researchers at the University of Oxford have discovered the specific gene mutations that are required for the development of leukaemia in children with Down’s syndrome. Children with Down’s syndrome have a 150-fold increased risk of myeloid leukaemia, and while some of the genetic causes of ... READ MORE
Patient involvement partnership sets priorities for rare inherited anaemias
On the occasion of Rare Diseases Day, marked every year on the last day of February, we are sharing this article about how patients, carers, clinicians and researchers are collaborating to decide key questions to shape future research into rare forms of anaemia. Patients with anaemia lack red ... READ MORE
Oxford researchers develop new technique to analyse cancer cells’ life history
A team of researchers from the University of Oxford has developed a new technique that allows scientists to reliably track genetic errors in individual cancer cells, and find out how these might lead to uncontrollable growth. The research by the MRC Weatherall Institute of Molecular Medicine, ... READ MORE
Researchers map leukaemia ‘family trees’ in patients treated with new drug
A team of international researchers, including experts from NIHR Oxford BRC, has for the first time mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains what happens when a patient ... READ MORE
New haematology patient group launched
The launch of a new patient engagement group for those with blood conditions has brought together patients, clinicians and researchers to discuss how to get patient involved in research. A screening of the film People are Messy at the Ultimate Picture Palace followed by a group discussion ... READ MORE
Oxford Centre for Haematology stages inaugural event
The new Oxford Centre for Haematology has held its inaugural event at Keble College, Oxford. The event, which will be held annually, was attended by around 200 academics, healthcare professionals and representatives of industry. Some speakers travelled from as far away as the United ... READ MORE
Oxford medical researchers win prestigious national awards
Leading health researchers in Oxford have been recognised in a prestigious national competition. Eight professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care ... READ MORE
Oxford Centre for Haematology launched
The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxford University Hospitals NHS Foundation Trust. The aim of this new virtual centre is to bring ... READ MORE
MDS Patient Support Group learn more about treatment of condition
Patients and relatives affected by Myelodysplastic Syndromes (MDS) have visited the MRC Weatherall Institute of Molecular Medicine (WIMM) at the John Radcliffe Hospital to find out more about advances in treating the condition. The members of the Oxford and Thames Valley MDS Patient Support Group ... READ MORE
Researchers thank Bloodwise fundraisers for funding critical leukaemia trial
Staff and patients at the Oxford Cancer Centre at the Churchill Hospital have thanked fundraisers for the Bloodwise charity who have raised enough money to fully fund a trial of a new leukaemia drug. The staff and patient Thelma, who has been on the trial, sent their appreciation in a video to ... READ MORE
New drug gives hope in fight against leukaemia
An international group of haematology scientists, including leading researchers in Oxford, have secured approval from the US Food and drug Administration (FDA) for a new leukaemia drug that has produced exciting results in clinical trials. The development of Enasidenib has given hope to people ... READ MORE
New clinical trial to tackle hard-to-treat leukaemia
A new clinical trial at Oxford’s Churchill Hospital plans to study the safety of a new experimental drug to treat a form of leukaemia, called Acute Myeloid Leukaemia (AML). Acute myeloid leukaemia is the most common aggressive blood cancer and there are about 2,200 new cases in the UK each year. ... READ MORE
Nomination for BRC-backed blood project
A project supported by the NIHR Oxford Biomedical Research Centre has been nominated for a leading patient safety award. The Real-Time Blood Transfusion Data and Decision Support project has been nominated in the Technology and IT to Improve Patient Safety category for the Patient Safety Awards ... READ MORE